Endokrinologisk udredning, behandling og opfølgning af polycystisk ovariesyndrom

Dorte Glintborg; Jørgen Rungby; Peter Eskildsen; Anne Pernille Hermann; Chalotte Willemann Stecher; Marianne Andersen; En arbejdsgruppe nedsat af Dansk Endokrinologisk Selskab

Endokrinologisk udredning, behandling og opfølgning af polycystisk ovariesyndrom

Translated title of the contribution: [Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome]

Dorte Glintborg, Jørgen Rungby, Peter Eskildsen, Anne Pernille Hermann, Chalotte Willemann Stecher, Marianne Andersen, En arbejdsgruppe nedsat af Dansk Endokrinologisk Selskab

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Polycystic ovary syndrome (PCOS) has a prevalence of 5-10% and is defined as oligomenorrhoea, hyperandrogenaemia and/or polycystic ovaries and the exclusion of other aetiologies for the patient's symptoms. There is currently no agreement on the initial evaluation programme for women referred with PCOS or on how the syndrome should be treated. Women with PCOS have an increased risk of the metabolic syndrome upon diagnosis and increased long-term risk of type 2 diabetes, cardiovascular disease and endometrial cancer. In the present overview, we give recommendations for relevant follow-up examination of patients with PCOS based on a search of the available literature.

Translated title of the contribution	[Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome]
Original language	Danish
Journal	Ugeskrift for Læger
Volume	172
Issue number	3
Pages (from-to)	196-9
Number of pages	4
ISSN	0041-5782
Publication status	Published - 18. Jan 2010

Cite this

@article{6cbebdf9df3b47e0a75606477cea5f81,

title = "Endokrinologisk udredning, behandling og opf{\o}lgning af polycystisk ovariesyndrom",

abstract = "Polycystic ovary syndrome (PCOS) has a prevalence of 5-10% and is defined as oligomenorrhoea, hyperandrogenaemia and/or polycystic ovaries and the exclusion of other aetiologies for the patient's symptoms. There is currently no agreement on the initial evaluation programme for women referred with PCOS or on how the syndrome should be treated. Women with PCOS have an increased risk of the metabolic syndrome upon diagnosis and increased long-term risk of type 2 diabetes, cardiovascular disease and endometrial cancer. In the present overview, we give recommendations for relevant follow-up examination of patients with PCOS based on a search of the available literature.",

keywords = "Female, Follow-Up Studies, Humans, Life Style, Polycystic Ovary Syndrome, Risk Factors",

author = "Dorte Glintborg and J{\o}rgen Rungby and Peter Eskildsen and Hermann, {Anne Pernille} and Stecher, {Chalotte Willemann} and Marianne Andersen and {En arbejdsgruppe nedsat af Dansk Endokrinologisk Selskab}",

year = "2010",

month = jan,

day = "18",

language = "Dansk",

volume = "172",

pages = "196--9",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "3",

}

TY - JOUR

T1 - Endokrinologisk udredning, behandling og opfølgning af polycystisk ovariesyndrom

AU - Glintborg, Dorte

AU - Rungby, Jørgen

AU - Eskildsen, Peter

AU - Hermann, Anne Pernille

AU - Stecher, Chalotte Willemann

AU - Andersen, Marianne

AU - En arbejdsgruppe nedsat af Dansk Endokrinologisk Selskab

PY - 2010/1/18

Y1 - 2010/1/18

N2 - Polycystic ovary syndrome (PCOS) has a prevalence of 5-10% and is defined as oligomenorrhoea, hyperandrogenaemia and/or polycystic ovaries and the exclusion of other aetiologies for the patient's symptoms. There is currently no agreement on the initial evaluation programme for women referred with PCOS or on how the syndrome should be treated. Women with PCOS have an increased risk of the metabolic syndrome upon diagnosis and increased long-term risk of type 2 diabetes, cardiovascular disease and endometrial cancer. In the present overview, we give recommendations for relevant follow-up examination of patients with PCOS based on a search of the available literature.

AB - Polycystic ovary syndrome (PCOS) has a prevalence of 5-10% and is defined as oligomenorrhoea, hyperandrogenaemia and/or polycystic ovaries and the exclusion of other aetiologies for the patient's symptoms. There is currently no agreement on the initial evaluation programme for women referred with PCOS or on how the syndrome should be treated. Women with PCOS have an increased risk of the metabolic syndrome upon diagnosis and increased long-term risk of type 2 diabetes, cardiovascular disease and endometrial cancer. In the present overview, we give recommendations for relevant follow-up examination of patients with PCOS based on a search of the available literature.

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Life Style

KW - Polycystic Ovary Syndrome

KW - Risk Factors

M3 - Tidsskriftartikel

C2 - 20089209

SN - 0041-5782

VL - 172

SP - 196

EP - 199

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 3

ER -

Endokrinologisk udredning, behandling og opfølgning af polycystisk ovariesyndrom

Abstract

Fingerprint

Cite this